2-Methyl-1-(3-sulphonatopropyl)quinolinium, 95.0%, 25g

1,4-Dioxane, min. 99.5%, for synthesis, stabilized, 500 ml, glass packaging

3-(4-MORPHOLIN-4-YLMETHYL-PHENYL)-3-OXO-PROPIONITRILE, 95.0%, 250mg

(1-Isopropyl-1H-pyrazol-5-yl)boronic acid, 95.0%, 10g

4-Oxopiperidine-3-carboxamide, 95.0%, 1g

2-(3-Bromo-5-fluorophenyl)acetic acid, 95.0%, 10g

Copper(I) acetate, 97.0%, 1g

4-BROMO-2-IODO(TRIFLUOROMETHOXY)BENZENE, 95.0%, 1g

3-Chloro-4-fluorobenzeneboronic acid, 98.0%, 100g

Methyl 1-cyclopropyl-1H-benzo[d][1,2,3]triazole-5-carboxylate, 95.0%, 25g

ethyl (2-amino-4-methyl-1,3-thiazol-5-yl)acetate, 95.0%, 1g

(3-Amino-2-methylphenyl)methanol, 97.0%, 50g

3-Ethoxy-3-methylazetidine hydrochloride, 95%, 250mg